— Know what they know.
Not Investment Advice

ZIMV NASDAQ

ZimVie Inc.
1W: +0.1% 1M: +0.6% 3M: +1.1% 1Y: +28.3% 3Y: +162.7%
$18.99
Last traded 2025-10-21 — delisted
NASDAQ · Healthcare · Medical - Devices · $535.6M mcap · 27M float · 2.66% daily turnover · Short 29% of daily vol

Balance Sheet Trends

Total Assets
$754M -37.5% ▼
5Y CAGR: -18.6%
Total Liabilities
$372M -53.3% ▼
5Y CAGR: -3.4%
Shareholders Equity
$382M -6.8% ▼
5Y CAGR: -25.5%
Cash & Investments
$75M +4.8% ▲
5Y CAGR: +15.2%
Total Debt
$233M -55.4% ▼
5Y CAGR: +22.0%
Net Debt
$158M -65.0% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2020FY2021FY2022FY2023FY2024
— Assets —
Cash$27M$100M$90M$72M$75M
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$27M$100M$90M$72M$75M
Net Receivables$194M$164M$75M$75M$72M
Inventory$283M$247M$234M$80M$75M
Other Current Assets$0$16M$299M$244M$19M
Total Current Assets$526M$537M$538M$483M$257M
Property, Plant & Equip.$183M$180M$148M$54M$47M
Goodwill & Intangibles$1.2B$1.0B$915M$376M$350M
Long-Term Investments$0-$130M$0$0$0
Other Non-Current Assets$75M$76M-$57M$292M$99M
Total Non-Current Assets$1.4B$1.3B$1.1B$722M$496M
Total Assets$1.9B$1.8B$1.6B$1.2B$754M
— Liabilities —
Accounts Payable$50M$45M$29M$28M$33M
Short-Term Debt$18M$0$0$0$0
Deferred Revenue$62M$55M$98M$0$0
Other Current Liabilities$49M$86M$109M$116M$72M
Total Current Liabilities$226M$185M$217M$174M$134M
Long-Term Debt$5M$0$532M$509M$220M
Other Non-Current Liab.$20M$16M$124M$104M$9M
Total Non-Current Liabilities$232M$191M$666M$622M$238M
Total Liabilities$459M$375M$883M$796M$372M
— Equity —
Common Stock$1.5B$1.5B$262K$271K$277K
Retained Earnings$0$0-$48M-$441M-$467M
Accumulated OCI$4M-$43M-$91M-$73M-$91M
Total Stockholders Equity$1.5B$1.5B$759M$409M$382M
Total Liabilities & Equity$1.9B$1.8B$1.6B$1.2B$754M
— Key Metrics —
Total Debt$89M$58M$564M$522M$233M
Net Debt$62M-$42M$475M$450M$158M
Total Investments$0-$130M$0$0$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms